Brighter receives SEK 29M from the company's management, board and key personnel.
The exercise period for Brighter's management, board and key personnel incentive programs 2014/2017 Series I & II and 2015/2018 Series I & II is now completed. The company has received a total of SEK 29,369,024 through the programs.
"This capital injection means that we with force can take on and maximize the commercialization of Actiste in, among other markets, the United Arab Emirates,” says Truls Sjöstedt, Brighter’s CEO and founder.
This exercise will increase the number of shares in Brighter with 3,383,136.
For further information, please contact:
Truls Sjöstedt, CEO
Telefon: +46 709 73 46 00
Ann Zetterberg, CFO
Tel: +46 708 37 21 23
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se
The Company's shares are listed on NASDAQOMX First North/BRIG. Brighter’s Certified Adviser on Nasdaq OMX First North is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, email@example.com, www.eminova.se.
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:30 CET on October 3, 2018.